Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04853329
Title Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Conjupro Biotherapeutics, Inc.
Indications

non-Hodgkin lymphoma

B-cell prolymphocytic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

Therapies

CPO107

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.